Ionis Pharmaceuticals Investors
Ionis Pharmaceuticals is a prominent biotechnology company headquartered in Carlsbad, California, established in 1989 The company specializes in the development of RNA-targeted therapeutics, leveraging its proprietary antisense technology platform Ionis has attracted significant investment, with partnerships and collaborations that enhance its research and development capabilities The firm is recognized for its innovative approach to addressing unmet medical needs across various therapeutic areas With a strong commitment to advancing drug discovery, Ionis Pharmaceuticals continues to play a vital role in the biotechnology industry
Acquisitions Number:
Made Acquisitions
Founded Date:
1989
Last Funding Type:
Post-IPO Debt
Headquarters:
USA
Investors Number:
4
Technology:
Biotechnology, Medical, Pharmaceutical
Employee Number:
251-500
Industry:
FemTech
Estimated Revenue:
$100M to $500M
Last Funding Date:
2021-04-08
Funding Status:
IPO
Investor Type:
Angel Groups
Total Funding:
751250000.0